Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $2.04M invested in Moleculin Biotech in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
60% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 5
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$46.1K | |
| 2 | +$44.4K | |
| 3 | +$21.3K | |
| 4 |
WIC
Woodmont Investment Counsel
Nashville,
Tennessee
|
+$8.87K |
| 5 |
HF
HRT Financial
New York
|
+$8.87K |
Top Sellers
| 1 | -$179K | |
| 2 | -$65.7K | |
| 3 | -$26.6K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$21.3K |
| 5 |
Barclays
London,
United Kingdom
|
-$5.32K |